secwatch.observer — SEC 8-K summary
======================================

Issuer:     Viracta Therapeutics, Inc. (—)
CIK:        0001061027
Form:       8-K
Filed at:   2025-01-31T23:59:59+00:00
Accession:  0000950170-25-011792
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Viracta Therapeutics to be delisted from Nasdaq effective Feb 4, 2025; expects OTC Pink listing under VIRX
--------------------------------------------------------------------------------

- Received Nasdaq delisting notice on Jan 31, 2025; trading suspended at open on Feb 4, 2025.
- Failed minimum bid price ($1.00) and stockholders' equity ($2.5M) continued listing requirements.
- Expects common stock to trade on OTC Pink Open Market under symbol VIRX; warns of reduced liquidity.
- No assurance of continued trading or sufficient volume on OTC Pink market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061027/000095017025011792/0000950170-25-011792-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061027/000095017025011792/virx-20250131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-011792

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer